LETHAL STAPHYLOCOCCUS-AUREUS-INDUCED SHOCK IN PRIMATES - PREVENTION OF DEATH WITH ANTI-TNF ANTIBODY

被引:111
作者
HINSHAW, LB
EMERSON, TE
TAYLOR, FB
CHANG, ACK
DUERR, M
PEER, GT
FLOURNOY, DJ
WHITE, GL
KOSANKE, SD
MURRAY, CK
XU, R
PASSEY, RB
FOURNEL, MA
机构
[1] CUTTER BIOL MILES INC,BERKELEY,CA
[2] UNIV OKLAHOMA,NORMAN,OK 73019
[3] OKLAHOMA MEM HOSP & CLIN,OKLAHOMA CITY,OK
关键词
D O I
10.1097/00005373-199210000-00013
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A successful experimental treatment for gram-positive sepsis to our knowledge has not been achieved. The objectives of this study were to develop a nonhuman primate model of lethal gram-positive sepsis employing the micro-organism Staphylococcus aureus and to determine the efficacy of treatment using monoclonal antibody (MAb) to tumor necrosis factor alpha (TNF). The antibody was administered intravenously, 15 mg/kg, 30 minutes after the beginning of a 2-hour infusion of S. aureus, 4 x 10(10) colony forming units/kilogram. The baboons infused with S. aureus demonstrated the release of the cytokines TNF and interleukin-6 (IL-6), but endotoxin was not observed in the plasma at any time. Treatment with antibody to TNF abolished the rise in serum TNF levels and reduced the increased levels of IL-6. Treatment with MAb to TNF prevented multiple organ failure and achieved permanent (>7 day) survival of all baboons.
引用
收藏
页码:568 / 573
页数:6
相关论文
共 20 条
[1]   TUMOR-NECROSIS-FACTOR AND SEPTIC SHOCK [J].
BAUD, L ;
CADRANEL, J ;
OFFENSTADT, G ;
LUQUEL, L ;
GUIDET, B ;
AMSTUTZ, P .
CRITICAL CARE MEDICINE, 1990, 18 (03) :349-350
[2]   A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) :653-658
[3]   PLASMA TUMOR NECROSIS FACTOR AND MORTALITY IN CRITICALLY ILL SEPTIC PATIENTS [J].
DEBETS, JMH ;
KAMPMEIJER, R ;
VANDERLINDEN, MPMH ;
BUURMAN, WA ;
VANDERLINDEN, CJ .
CRITICAL CARE MEDICINE, 1989, 17 (06) :489-494
[4]   A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES [J].
ESPEVIK, T ;
NISSENMEYER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) :99-105
[5]   ANTIBODIES TO CACHECTIN TUMOR NECROSIS FACTOR REDUCE INTERLEUKIN-1-BETA AND INTERLEUKIN-6 APPEARANCE DURING LETHAL BACTEREMIA [J].
FONG, YM ;
TRACEY, KJ ;
MOLDAWER, LL ;
HESSE, DG ;
MANOGUE, KB ;
KENNEY, JS ;
LEE, AT ;
KUO, GC ;
ALLISON, AC ;
LOWRY, SF ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) :1627-1633
[6]  
FONG YM, 1989, J IMMUNOL, V142, P2321
[7]   FUNCTIONAL DISCRIMINATION BETWEEN INTERLEUKIN-6 AND INTERLEUKIN-1 [J].
HELLE, M ;
BOEIJE, L ;
AARDEN, LA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (10) :1535-1540
[8]  
HINSHAW LB, 1988, CIRC SHOCK, V26, P257
[9]  
HINSHAW LB, 1990, CIRC SHOCK, V30, P279
[10]   EFFECTIVENESS OF STEROID-ANTIBIOTIC TREATMENT IN PRIMATES ADMINISTERED LD100 ESCHERICHIA-COLI [J].
HINSHAW, LB ;
BELLERTODD, BK ;
ARCHER, LT ;
BENJAMIN, B ;
FLOURNOY, DJ ;
PASSEY, R ;
WILSON, MF .
ANNALS OF SURGERY, 1981, 194 (01) :51-56